Open AccessAbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
Author(s) -
Joel Schlessinger,
Daniel P. Friedmann,
Flor Mayoral,
Deanne Mraz Robinson,
DeeAnna Glaser,
Douglas C. Wu,
Keith Marcus,
Michael Somenek,
Xiaoming Lin
Publication year - 2021
Publication title -
journal of drugs in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 62
ISSN - 1545-9616
DOI - 10.36849/jdd.6130
Subject(s) - medicine , placebo , vial , randomized controlled trial , clinical endpoint , adverse effect , patient satisfaction , surgery , chemistry , alternative medicine , pathology
Increasing the reconstitution and injection volumes of abobotulinumtoxinA (aboBoNT-A) could provide more options for aesthetic healthcare professionals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom